In lung cancer, KRAS mutations could regulate the transcription of angiogenesis‐related genes, ultimately leading to tumor neovascularization.[81] These regulatory effects of KRAS mutations on the stromal microenvironment provide new mechanistic insights into the protumorigenic roles of KRAS. Here, KRAS is linked to neoplasm.